Document is current

Article History

Accepted: 3 April 2025

First Online: 3 July 2025

Declarations

:

: Open Access funding enabled and organized by Projekt DEAL. The authors have not received a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. The guideline-development process was not supported financially; all members of the working groups were volunteers. The IFOM received funding from the lead professional organization (DGSP) for the preparation of the synopsis and the implementation of the surveys, but there was no further financial support.

: Information on the management of potential conflicts of interest is listed in the Supplementary Material (S1). Below, only relevant competing interests are listed: C.J., B.W., A.N., and T.S. are members of the DGSP executive board. C.K. is the head of the DGSP office. A.H., M.C., T.K., K.R., A.N., F.M., H.S., C.R., F.M., K.K., P.P., and A.C. are members of the DGSP scientific board/experts. K.R. is the owner of a software company for metabolic endurance diagnostics (Ergonizer Software e.K., Germany). T.S. received research funding from an ergometer manufacturer (Ergoline GmbH, Germany). All other authors declare that they have no competing interests.

: The data presented in this study are available on reasonable request from the corresponding author.

: Not applicable.

: Not applicable.

: C.J. conceived the idea for the consensus statement. C.J., A.H., A.N., and B.W. formed the consensus groups. C.J., B.W., A.N., A.H., A.C., C.R., and K.K. led the working groups. K.G. and A.W. ensured compliance with the predefined guideline methodology. All authors were included in the development of the recommendations. They contributed to reviewing and giving feedback on each iteration of the consensus draft. All authors read and approved the final version of the manuscript.